Pharmacist Training and Patient-Centered Diabetes Care

Published Online: Friday, May 2, 2014
Follow Pharmacy_Times:
In this video, Starlin Haydon-Greatting, MS, BSPharm, FAPHA, director of clinical programs at the Illinois Pharmacists Association, discusses the range of education and training that prepares pharmacists to play a role in patient-centered diabetes care.

This interview was recorded at the American Journal of Managed Care's live meeting on Patient-Centered Diabetes Care, held in Princeton, NJ.

Related Articles
The FDA has approved the intravitreal implant, Iluvien 0.19 mg, as the first long-term treatment for diabetic macular edema.
Pharmacists who participate in community-based diabetes care teams play a pivotal role in reducing A1C levels among patients with poorly controlled diabetes.
The dexamethasone intravitreal implant, Ozurdex, is now indicated to treat all patients with diabetic macular edema.
The FDA has cleared the Nova StatStrip Glucose Hospital Meter System to become the first blood glucose monitoring system for use in critically ill patients who have been hospitalized.
Latest Issues
$auto_registration$